JP2024037864A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2024037864A5 JP2024037864A5 JP2023209915A JP2023209915A JP2024037864A5 JP 2024037864 A5 JP2024037864 A5 JP 2024037864A5 JP 2023209915 A JP2023209915 A JP 2023209915A JP 2023209915 A JP2023209915 A JP 2023209915A JP 2024037864 A5 JP2024037864 A5 JP 2024037864A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- human
- rpe
- rpe cells
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025120956A JP2025161815A (ja) | 2011-11-14 | 2025-07-18 | ヒトｒｐｅ細胞医薬品およびその使用 |
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161559521P | 2011-11-14 | 2011-11-14 | |
| US61/559,521 | 2011-11-14 | ||
| US201261589741P | 2012-01-23 | 2012-01-23 | |
| US61/589,741 | 2012-01-23 | ||
| US201261724047P | 2012-11-08 | 2012-11-08 | |
| US61/724,047 | 2012-11-08 | ||
| JP2019098508A JP6899865B2 (ja) | 2011-11-14 | 2019-05-27 | ヒトｒｐｅ細胞医薬品およびその使用 |
| JP2021049493A JP7081016B2 (ja) | 2011-11-14 | 2021-03-24 | ヒトｒｐｅ細胞医薬品およびその使用 |
| JP2022084915A JP7404441B2 (ja) | 2011-11-14 | 2022-05-25 | ヒトｒｐｅ細胞医薬品およびその使用 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022084915A Division JP7404441B2 (ja) | 2011-11-14 | 2022-05-25 | ヒトｒｐｅ細胞医薬品およびその使用 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025120956A Division JP2025161815A (ja) | 2011-11-14 | 2025-07-18 | ヒトｒｐｅ細胞医薬品およびその使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024037864A JP2024037864A (ja) | 2024-03-19 |
| JP2024037864A5 true JP2024037864A5 (enExample) | 2024-08-22 |
| JP7716463B2 JP7716463B2 (ja) | 2025-07-31 |
Family
ID=47470610
Family Applications (7)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014541421A Active JP6506023B2 (ja) | 2011-11-14 | 2012-11-14 | ヒトｒｐｅ細胞医薬品およびその使用 |
| JP2017183914A Active JP6563996B2 (ja) | 2011-11-14 | 2017-09-25 | ヒトｒｐｅ細胞医薬品およびその使用 |
| JP2019098508A Active JP6899865B2 (ja) | 2011-11-14 | 2019-05-27 | ヒトｒｐｅ細胞医薬品およびその使用 |
| JP2021049493A Active JP7081016B2 (ja) | 2011-11-14 | 2021-03-24 | ヒトｒｐｅ細胞医薬品およびその使用 |
| JP2022084915A Active JP7404441B2 (ja) | 2011-11-14 | 2022-05-25 | ヒトｒｐｅ細胞医薬品およびその使用 |
| JP2023209915A Active JP7716463B2 (ja) | 2011-11-14 | 2023-12-13 | ヒトｒｐｅ細胞医薬品およびその使用 |
| JP2025120956A Pending JP2025161815A (ja) | 2011-11-14 | 2025-07-18 | ヒトｒｐｅ細胞医薬品およびその使用 |
Family Applications Before (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014541421A Active JP6506023B2 (ja) | 2011-11-14 | 2012-11-14 | ヒトｒｐｅ細胞医薬品およびその使用 |
| JP2017183914A Active JP6563996B2 (ja) | 2011-11-14 | 2017-09-25 | ヒトｒｐｅ細胞医薬品およびその使用 |
| JP2019098508A Active JP6899865B2 (ja) | 2011-11-14 | 2019-05-27 | ヒトｒｐｅ細胞医薬品およびその使用 |
| JP2021049493A Active JP7081016B2 (ja) | 2011-11-14 | 2021-03-24 | ヒトｒｐｅ細胞医薬品およびその使用 |
| JP2022084915A Active JP7404441B2 (ja) | 2011-11-14 | 2022-05-25 | ヒトｒｐｅ細胞医薬品およびその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025120956A Pending JP2025161815A (ja) | 2011-11-14 | 2025-07-18 | ヒトｒｐｅ細胞医薬品およびその使用 |
Country Status (23)
| Country | Link |
|---|---|
| US (4) | US20130195806A1 (enExample) |
| EP (2) | EP2780022B2 (enExample) |
| JP (7) | JP6506023B2 (enExample) |
| KR (1) | KR102054904B1 (enExample) |
| CN (2) | CN113786417A (enExample) |
| AU (5) | AU2012340020A1 (enExample) |
| CA (2) | CA2855941A1 (enExample) |
| CY (1) | CY1121819T1 (enExample) |
| DK (1) | DK2780022T4 (enExample) |
| ES (1) | ES2734453T3 (enExample) |
| FI (1) | FI2780022T4 (enExample) |
| GB (1) | GB2496969A (enExample) |
| HK (1) | HK1202456A1 (enExample) |
| HR (1) | HRP20191110T1 (enExample) |
| HU (1) | HUE044778T2 (enExample) |
| IL (5) | IL287381B2 (enExample) |
| LT (1) | LT2780022T (enExample) |
| PL (1) | PL2780022T3 (enExample) |
| PT (1) | PT2780022T (enExample) |
| RS (1) | RS59050B1 (enExample) |
| SI (1) | SI2780022T1 (enExample) |
| TW (5) | TWI655286B (enExample) |
| WO (1) | WO2013074681A1 (enExample) |
Families Citing this family (79)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7794704B2 (en) | 2004-01-23 | 2010-09-14 | Advanced Cell Technology, Inc. | Methods for producing enriched populations of human retinal pigment epithelium cells for treatment of retinal degeneration |
| CA2937099A1 (en) | 2004-01-23 | 2005-08-04 | Astellas Institute For Regenerative Medicine | Improved modalities for the treatment of degenerative diseases of the retina |
| EP2209888B1 (en) | 2007-10-12 | 2019-12-04 | Astellas Institute for Regenerative Medicine | Improved methods of producing rpe cells and compositions of rpe cells |
| EP2412800A1 (en) | 2010-07-29 | 2012-02-01 | Koninklijke Nederlandse Akademie van Wetenschappen | Liver organoid, uses thereof and culture method for obtaining them |
| IL281453B (en) | 2009-11-17 | 2022-07-01 | Astellas Inst For Regenerative Medicine | Methods for preparing human rpe cells and pharmaceutical preparations of human rpe cells |
| US10852069B2 (en) | 2010-05-04 | 2020-12-01 | Fractal Heatsink Technologies, LLC | System and method for maintaining efficiency of a fractal heat sink |
| EP3875599B1 (en) | 2010-07-23 | 2024-12-11 | Astellas Institute for Regenerative Medicine | Methods for detection of rare subpopulations of cells and highly purified compositions of cells |
| US11021733B2 (en) | 2011-09-26 | 2021-06-01 | Qiagen Gmbh | Stabilization and isolation of extracellular nucleic acids |
| AU2012314514B2 (en) | 2011-09-26 | 2018-03-15 | Qiagen Gmbh | Stabilisation and isolation of extracellular nucleic acids |
| WO2013045458A1 (en) | 2011-09-26 | 2013-04-04 | Preanalytix Gmbh | Stabilisation and isolation of extracellular nucleic acids |
| IL287381B2 (en) * | 2011-11-14 | 2024-04-01 | Astellas Inst For Regenerative Medicine | Pharmaceutical preparations of human rpe cells and uses thereof |
| JP6608280B2 (ja) | 2012-09-25 | 2019-11-20 | キアゲン ゲーエムベーハー | 生物学的試料の安定化 |
| DK2951290T3 (en) | 2013-02-01 | 2018-01-22 | Us Health | PROCEDURE FOR PREPARING RETINAL PIGMENTAL EPIT (RPE) CELLS FROM INDUCED PLURIPOTENT STEM CELLS (IPSCS) |
| EP2976424B1 (en) | 2013-03-18 | 2018-10-03 | Qiagen GmbH | Stabilisation of biological samples |
| US20160281133A1 (en) | 2013-03-18 | 2016-09-29 | Qiagen Gmbh | Stabilization and isolation of extracellular nucleic acids |
| BR112016011096A2 (pt) | 2013-11-27 | 2017-09-19 | Kyoto Prefectural Public Univ Corp | Aplicação de laminina à cultura de célula endotelial da córnea |
| AU2014363032A1 (en) | 2013-12-11 | 2016-06-09 | Pfizer Limited | Method for producing retinal pigment epithelial cells |
| EP2898896A1 (en) * | 2014-01-22 | 2015-07-29 | Université Pierre et Marie Curie (Paris 6) | Agents for use in the treatment of retinal inflammation |
| CN106102766A (zh) * | 2014-01-22 | 2016-11-09 | 皮埃尔与玛丽·居里大学 - 巴黎第六大学 | 用于治疗视网膜炎症的试剂 |
| CA2940692C (en) * | 2014-03-18 | 2025-07-08 | Qiagen Gmbh | STABILIZATION AND ISOLATION OF EXTRACELLULAR NUCLEIC ACIDS |
| WO2015175504A1 (en) * | 2014-05-12 | 2015-11-19 | The Johns Hopkins University | Differentiation of human pluripotent stem cells into retinal pigment epithelium using hif1 inhibitors |
| US10457915B2 (en) | 2014-05-15 | 2019-10-29 | International Stem Cell Corporation | Chemical differentiation of pluripotentstem cells into retinal epithelial cells |
| WO2015173425A1 (en) | 2014-05-16 | 2015-11-19 | Koninklijke Nederlandse Akademie Van Wetenschappen | Improved culture method for organoids |
| WO2015200905A2 (en) | 2014-06-28 | 2015-12-30 | Oligasis, Llc | Dual pdgf/vegf antagonists |
| US20160095307A1 (en) | 2014-10-07 | 2016-04-07 | NuTech Medical, Inc. | Method and composition for hypothermic storage of placental tissue |
| EP3207128B1 (en) | 2014-10-17 | 2022-07-27 | Kodiak Sciences Inc. | Butyrylcholinesterase zwitterionic polymer conjugates |
| MX387839B (es) * | 2014-10-31 | 2025-03-04 | Senju Pharma Co | Laminina para usarse en el tratamiento de una enfermedad, un trastorno o una afección de un endotelio de córnea. |
| JP6770435B2 (ja) * | 2014-10-31 | 2020-10-14 | 京都府公立大学法人 | ラミニンによる網膜および神経の新規治療 |
| EP3233093B1 (en) * | 2014-12-18 | 2022-06-29 | Sorbonne Universite | Transgenic rpe cells overexpressing otx2 for the treatment of retinal degeneration |
| AU2015373050B2 (en) | 2014-12-30 | 2022-09-29 | Cell Cure Neurosciences Ltd. | RPE cell populations and methods of generating same |
| CA2972700A1 (en) * | 2014-12-30 | 2016-07-07 | Cell Cure Neurosciences Ltd. | Methods of treating retinal diseases |
| US20180011092A1 (en) | 2014-12-30 | 2018-01-11 | Cell Cure Neurosciences Ltd. | Assessing retinal pigment epithelial cell populations |
| EP3869195B1 (en) * | 2015-03-23 | 2024-03-20 | Astellas Institute for Regenerative Medicine | Improved assays for potency of human retinal pigment epithelium (rpe) cells and photoreceptor progenitors |
| CN105013010B (zh) * | 2015-07-07 | 2018-01-12 | 中山大学中山眼科中心 | 一种辅助iPS‑RPE移植的层粘连蛋白膜 |
| CN108138144A (zh) | 2015-08-05 | 2018-06-08 | 细胞治疗神经科学有限公司 | 视网膜色素上皮细胞的制备 |
| KR102411018B1 (ko) | 2015-08-18 | 2022-06-20 | 아스텔라스 인스티튜트 포 리제너러티브 메디슨 | 임상 제제 |
| US11162070B2 (en) * | 2015-09-08 | 2021-11-02 | FUJIFILM Cellular Dynamics, Inc. | MACS-based purification of stem cell-derived retinal pigment epithelium |
| JP7166169B2 (ja) | 2015-11-20 | 2022-11-07 | キアゲン ゲーエムベーハー | 細胞外核酸の滅菌のための滅菌組成物を調製する方法 |
| IL290457B2 (en) | 2015-12-30 | 2025-02-01 | Kodiak Sciences Inc | Antibodies and their conjugates |
| GB201603569D0 (en) | 2016-03-01 | 2016-04-13 | Koninklijke Nederlandse Akademie Van Wetenschappen | Improved differentiation method |
| CN106420809B (zh) * | 2016-08-31 | 2017-08-08 | 浙江济民制药股份有限公司 | 一种眼科手术灌注液 |
| US12215349B2 (en) * | 2016-12-13 | 2025-02-04 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Methods of preparing an isolated or purified population of thymic emigrant cells and methods of treatment using same |
| EP3824906A1 (en) | 2016-12-21 | 2021-05-26 | Amgen Inc. | Anti-tnf alpha antibody formulations |
| US11076984B2 (en) * | 2017-03-13 | 2021-08-03 | Gyroscope Therapeutics Limited | Method of performing subretinal drainage and agent delivery |
| US20200085882A1 (en) * | 2017-03-16 | 2020-03-19 | Lineage Cell Therapeutics, Inc. | Methods for measuring therapeutic effects of retinal disease therapies |
| CN110662549A (zh) * | 2017-05-01 | 2020-01-07 | 路易斯安娜州立大学监测委员会，农业和机械学院 | 用于治疗眼病的组合物和方法 |
| GB201721615D0 (en) | 2017-12-21 | 2018-02-07 | Koninklijke Nederlandse Akademie Van Wetenschappen | Immune cell organoid co-cultures |
| BR112020013238A2 (pt) * | 2017-12-29 | 2020-12-01 | Cell Cure Neurosciences Ltd. | composição e método para formular células do epitélio pigmentar da retina bem como uso da dita composição para tratar uma condição retiniana |
| CN112351755A (zh) | 2018-02-22 | 2021-02-09 | 伊万提斯公司 | 眼部植入物和输送系统 |
| CA3092588A1 (en) * | 2018-03-02 | 2019-09-06 | Kodiak Sciences Inc. | Il-6 antibodies and fusion constructs and conjugates thereof |
| CA3119041A1 (en) * | 2018-11-19 | 2020-05-28 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Biodegradable tissue replacement implant and its use |
| GB201819224D0 (en) | 2018-11-26 | 2019-01-09 | Koninklijke Nederlandse Akademie Van Wetenschappen | Hepatocyte expansion methods |
| BR112021009913A2 (pt) * | 2018-12-05 | 2021-08-17 | Abeona Therapeutics, Inc. | vetor viral adeno-associado recombinante para inserção gênica |
| US12678067B1 (en) | 2019-03-20 | 2026-07-14 | Biological Art Group, Inc. | Telemetry implants |
| CN113874494A (zh) * | 2019-05-28 | 2021-12-31 | 豪夫迈·罗氏有限公司 | 产生单核细胞祖细胞的方法 |
| PE20240329A1 (es) | 2019-06-05 | 2024-02-27 | Regeneron Pharma | Dispositivos y metodos para administracion de dosis de precision |
| KR102198942B1 (ko) * | 2019-07-02 | 2021-01-05 | 의료법인 성광의료재단 | Pedf를 발현하거나 모세포에 비하여 pedf를 과발현하도록 유전적으로 조작된 중간엽 줄기세포 |
| WO2021034784A1 (en) | 2019-08-16 | 2021-02-25 | Poltorak Technologies, LLC | Device and method for medical diagnostics |
| CA3157509A1 (en) | 2019-10-10 | 2021-04-15 | Kodiak Sciences Inc. | Methods of treating an eye disorder |
| AU2020374884A1 (en) | 2019-10-30 | 2022-06-09 | Astellas Institute For Regenerative Medicine | Methods for producing retinal pigment epithelium cells |
| EP4061942A4 (en) * | 2019-11-22 | 2023-12-20 | Sigilon Therapeutics, Inc. | MONOCLONAL CELL LINES EXPRESSING AN EXOGENEOUS SUBSTANCE AND THEIR USES |
| IL294874B1 (en) | 2020-01-21 | 2026-06-01 | Takeda Pharmaceutical Co Limited | Preparations and methods for cryopreservation of cells |
| AU2021217222A1 (en) * | 2020-02-07 | 2022-09-29 | The Trustees Of Columbia University In The City Of New York | Reprogramming the metabolome to delay onset or treat neurodegeneration |
| TW202216158A (zh) * | 2020-07-10 | 2022-05-01 | 國立研究開發法人理化學研究所 | 網膜色素上皮細胞之移植用存活促進劑 |
| CN112544612A (zh) * | 2020-12-18 | 2021-03-26 | 江苏艾尔康生物医药科技有限公司 | 冻存液及其在rpe细胞冻存中的应用 |
| CN112834411B (zh) * | 2021-01-07 | 2022-05-27 | 上海交通大学 | 应用于质谱流式技术的金属纳米探针及制备方法和应用 |
| EP4284415A4 (en) * | 2021-01-26 | 2024-12-11 | Sigilon Therapeutics, Inc. | BIOCOMPATIBLE DEVICES FOR CELL-BASED THERAPIES AND RELATED METHODS |
| CN112926116B (zh) * | 2021-03-01 | 2023-02-17 | 哈尔滨工业大学 | 一种基于虚拟现实的体育馆火灾疏散行为数据收集系统及其收集方法 |
| US12649031B2 (en) | 2021-09-08 | 2026-06-09 | Regeneron Pharmaceuticals, Inc. | Methods for delivering agents with pre-filled syringes to minimize intraocular inflammation |
| CN114246938A (zh) * | 2022-01-25 | 2022-03-29 | 中山大学中山眼科中心 | Il-4在制备用于治疗视网膜变性疾病药物中的应用 |
| WO2023149420A1 (ja) * | 2022-02-01 | 2023-08-10 | 株式会社坪田ラボ | 近視を予防または治療するための方法および組成物 |
| CN114561356B (zh) * | 2022-03-09 | 2022-09-13 | 北京呈诺医学科技有限公司 | 影响细胞因子分泌的方法及应用 |
| CN118871141A (zh) * | 2022-03-16 | 2024-10-29 | 住友制药株式会社 | 移植用介质 |
| USD1120314S1 (en) | 2022-11-30 | 2026-03-24 | Regeneron Pharmaceuticals, Inc. | Dose delivery device |
| EP4698206A1 (fr) * | 2023-04-21 | 2026-02-25 | PulseSight Therapeutics | Compositions à base de décorine pour la réparation et la régéneration de l'épithélium pigmentaire de la rétine |
| EP4704870A1 (en) * | 2023-05-05 | 2026-03-11 | The Regents of University of California | Retinal pigment epithelium cell therapy |
| CN117625536B (zh) * | 2024-01-26 | 2024-04-30 | 中国人民解放军总医院第三医学中心 | 一种人视网膜色素上皮细胞的纯化、培养方法 |
| JP2025139102A (ja) | 2024-03-12 | 2025-09-26 | 株式会社サトー | プリンタ、プログラム、プリンタの情報処理方法 |
| WO2026110810A1 (ja) * | 2024-11-21 | 2026-05-28 | セントラル硝子株式会社 | 凍結解凍した移植用三次元細胞培養体を浸すための溶液、溶液製造方法、移植用三次元細胞培養体の凍結解凍物、凍結解凍物を得る製造方法、溶液の使用方法、および、移植用キット |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4138205A (en) | 1975-12-15 | 1979-02-06 | Hydro Pulse Corporation | Movable stator walls permitting access to tubing in peristaltic pump |
| US5610753A (en) | 1991-12-12 | 1997-03-11 | Eastman Kodak Company | Optical design of laser scanner to reduce thermal sensitivity |
| GB9608145D0 (en) * | 1996-04-19 | 1996-06-26 | British Tech Group | Wound healing |
| US20040086494A1 (en) * | 1996-10-07 | 2004-05-06 | John Constance Mary | Immune privileged cells for delivery of proteins and peptides |
| US5998423A (en) | 1996-10-08 | 1999-12-07 | Therasys, Inc. | Methods for modulating melanin production |
| US6440933B1 (en) | 1997-09-10 | 2002-08-27 | University Of Florida | Compounds and method for the prevention and treatment of diabetic retinopathy |
| JP2002500202A (ja) * | 1998-01-02 | 2002-01-08 | タイタン ファーマシューティカルズ， インコーポレイテッド | 免疫優位部位の生成のための色素性網膜上皮細胞の使用 |
| US7410798B2 (en) | 2001-01-10 | 2008-08-12 | Geron Corporation | Culture system for rapid expansion of human embryonic stem cells |
| US6943153B1 (en) | 1999-03-15 | 2005-09-13 | The Regents Of The University Of California | Use of recombinant gene delivery vectors for treating or preventing diseases of the eye |
| US6331313B1 (en) | 1999-10-22 | 2001-12-18 | Oculex Pharmaceticals, Inc. | Controlled-release biocompatible ocular drug delivery implant devices and methods |
| US6576422B1 (en) * | 2000-10-17 | 2003-06-10 | Rohm And Haas Company | Method for identifying products employing gene expression |
| US6699493B2 (en) | 2000-11-29 | 2004-03-02 | Oculex Pharmaceuticals, Inc. | Method for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor |
| WO2002087530A1 (en) * | 2001-04-27 | 2002-11-07 | The General Hospital Corporation | Tyrosinase assay |
| EP1427835B1 (en) * | 2001-08-08 | 2016-01-20 | The Trustees of the University of Pennsylvania | Method for purification of viral vectors having proteins which bind sialic acid |
| US20030232430A1 (en) | 2001-11-26 | 2003-12-18 | Advanced Cell Technology | Methods for making and using reprogrammed human somatic cell nuclei and autologous and isogenic human stem cells |
| WO2003060083A2 (en) | 2002-01-15 | 2003-07-24 | Advanced Cell Technology, Inc. | Cloning b and t lymphocytes |
| US20040091936A1 (en) | 2002-05-24 | 2004-05-13 | Michael West | Bank of stem cells for producing cells for transplantation having HLA antigens matching those of transplant recipients, and methods for making and using such a stem cell bank |
| US7803750B2 (en) | 2002-07-29 | 2010-09-28 | Duke University | Method of modulating melanin production |
| US7794704B2 (en) * | 2004-01-23 | 2010-09-14 | Advanced Cell Technology, Inc. | Methods for producing enriched populations of human retinal pigment epithelium cells for treatment of retinal degeneration |
| CA2937099A1 (en) * | 2004-01-23 | 2005-08-04 | Astellas Institute For Regenerative Medicine | Improved modalities for the treatment of degenerative diseases of the retina |
| US7309487B2 (en) * | 2004-02-09 | 2007-12-18 | George Inana | Methods and compositions for detecting and treating retinal diseases |
| EP1812554A4 (en) | 2004-11-04 | 2008-10-08 | Advanced Cell Tech Inc | DERIVATION OF EMBRYONAL STEM CELLS |
| US7893315B2 (en) | 2004-11-04 | 2011-02-22 | Advanced Cell Technology, Inc. | Derivation of embryonic stem cells and embryo-derived cells |
| ZA200901914B (en) * | 2006-09-22 | 2010-06-30 | Riken | Stem cell culture medium and method |
| EP2209888B1 (en) * | 2007-10-12 | 2019-12-04 | Astellas Institute for Regenerative Medicine | Improved methods of producing rpe cells and compositions of rpe cells |
| GB0806746D0 (en) | 2008-04-14 | 2008-05-14 | Ucl Business Plc | Membrane |
| BRPI0910575A2 (pt) * | 2008-04-18 | 2017-06-06 | Arizona Board Of Regents A Body Corp Of The State Of Arizona Acting For And Behalf Of The Univ Of Ar | métodos para tratar degeneração macular relacionada com a idade, para limitar desenvolvimento de degeneração macular relacionada com a idade, e para identificar compostos para tratar degeneração macular relacionada com a idade, e, composição |
| IL281453B (en) * | 2009-11-17 | 2022-07-01 | Astellas Inst For Regenerative Medicine | Methods for preparing human rpe cells and pharmaceutical preparations of human rpe cells |
| EP3875599B1 (en) * | 2010-07-23 | 2024-12-11 | Astellas Institute for Regenerative Medicine | Methods for detection of rare subpopulations of cells and highly purified compositions of cells |
| US20110052678A1 (en) * | 2010-11-05 | 2011-03-03 | Shantha Totada R | Method for treating age related macular degeneration |
| CA2831609C (en) | 2011-03-30 | 2019-06-11 | Cellular Dynamics International, Inc. | Priming of pluripotent stem cells for neural differentiation |
| EP2702135B1 (en) * | 2011-04-29 | 2019-04-17 | University of Southern California | Method of cryopreservation of stem cell-derived retinal pigment epithelial cells on polymeric substrate |
| IL287381B2 (en) | 2011-11-14 | 2024-04-01 | Astellas Inst For Regenerative Medicine | Pharmaceutical preparations of human rpe cells and uses thereof |
| PL3189135T3 (pl) * | 2014-09-05 | 2021-12-20 | Astellas Institute For Regenerative Medicine | Komórki zwojowe siatkówki i ich progenitory |
-
2012
- 2012-11-14 IL IL287381A patent/IL287381B2/en unknown
- 2012-11-14 GB GB1220511.8A patent/GB2496969A/en not_active Withdrawn
- 2012-11-14 CN CN202110854081.1A patent/CN113786417A/zh active Pending
- 2012-11-14 HR HRP20191110TT patent/HRP20191110T1/hr unknown
- 2012-11-14 CA CA2855941A patent/CA2855941A1/en active Pending
- 2012-11-14 RS RS20190890A patent/RS59050B1/sr unknown
- 2012-11-14 US US13/676,999 patent/US20130195806A1/en not_active Abandoned
- 2012-11-14 FI FIEP12848968.9T patent/FI2780022T4/fi active
- 2012-11-14 IL IL320536A patent/IL320536A/en unknown
- 2012-11-14 HU HUE12848968 patent/HUE044778T2/hu unknown
- 2012-11-14 WO PCT/US2012/065091 patent/WO2013074681A1/en not_active Ceased
- 2012-11-14 CN CN201280066325.9A patent/CN104080464A/zh active Pending
- 2012-11-14 HK HK15103225.4A patent/HK1202456A1/xx unknown
- 2012-11-14 TW TW101142511A patent/TWI655286B/zh active
- 2012-11-14 LT LTEP12848968.9T patent/LT2780022T/lt unknown
- 2012-11-14 PL PL12848968T patent/PL2780022T3/pl unknown
- 2012-11-14 TW TW111133463A patent/TWI842079B/zh active
- 2012-11-14 EP EP12848968.9A patent/EP2780022B2/en active Active
- 2012-11-14 EP EP19164689.2A patent/EP3563860A1/en active Pending
- 2012-11-14 KR KR1020147016228A patent/KR102054904B1/ko not_active Expired - Fee Related
- 2012-11-14 PT PT12848968T patent/PT2780022T/pt unknown
- 2012-11-14 AU AU2012340020A patent/AU2012340020A1/en not_active Abandoned
- 2012-11-14 JP JP2014541421A patent/JP6506023B2/ja active Active
- 2012-11-14 TW TW113103167A patent/TW202434266A/zh unknown
- 2012-11-14 CA CA3178098A patent/CA3178098A1/en active Pending
- 2012-11-14 TW TW109136186A patent/TWI785403B/zh active
- 2012-11-14 SI SI201231636T patent/SI2780022T1/sl unknown
- 2012-11-14 ES ES12848968T patent/ES2734453T3/es active Active
- 2012-11-14 TW TW107102515A patent/TWI719277B/zh active
- 2012-11-14 IL IL308205A patent/IL308205B2/en unknown
- 2012-11-14 DK DK12848968.9T patent/DK2780022T4/da active
-
2014
- 2014-05-13 IL IL232600A patent/IL232600B/en active IP Right Grant
-
2015
- 2015-05-15 US US14/713,108 patent/US20150366915A1/en not_active Abandoned
-
2017
- 2017-09-08 AU AU2017225146A patent/AU2017225146C1/en active Active
- 2017-09-25 JP JP2017183914A patent/JP6563996B2/ja active Active
-
2019
- 2019-02-20 AU AU2019201201A patent/AU2019201201B2/en active Active
- 2019-05-27 JP JP2019098508A patent/JP6899865B2/ja active Active
- 2019-07-09 CY CY20191100720T patent/CY1121819T1/el unknown
-
2020
- 2020-03-05 IL IL273107A patent/IL273107B/en unknown
- 2020-07-13 US US16/927,068 patent/US20200405767A1/en not_active Abandoned
-
2021
- 2021-03-24 JP JP2021049493A patent/JP7081016B2/ja active Active
- 2021-07-06 AU AU2021204719A patent/AU2021204719B2/en active Active
-
2022
- 2022-05-25 JP JP2022084915A patent/JP7404441B2/ja active Active
-
2023
- 2023-12-13 JP JP2023209915A patent/JP7716463B2/ja active Active
-
2024
- 2024-10-10 US US18/911,566 patent/US20250134932A1/en active Pending
-
2025
- 2025-02-21 AU AU2025201277A patent/AU2025201277A1/en active Pending
- 2025-07-18 JP JP2025120956A patent/JP2025161815A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3139914B1 (en) | Compounds for treating ophthalmic diseases and disorders | |
| IL308205B1 (en) | Pharmaceutical preparations of human rpe cells and uses thereof | |
| WO2024067874A1 (zh) | 一种改性壳聚糖及其在大分子活性成分递送中的应用 | |
| CN114404450B (zh) | 一种温敏型干细胞外泌体即型凝胶 | |
| CN101810563B (zh) | 他克莫司眼用在体凝胶制剂及其制备方法 | |
| US20240366565A1 (en) | Use of Verteporfin to Modulate Wound Healing After an Ocular Surgical Procedure or Ocular Injury | |
| TW200410699A (en) | Use of ANECORTAVE acetate for the protection of visual acuity in patients with age related macular degeneration | |
| JP2016121163A (ja) | 眼内でのコルチコステロイド使用に伴う眼圧の発生を減少させる方法 | |
| CN111870702B (zh) | 一种纳米眼用药物的制备方法及其应用 | |
| Rizzo et al. | Safety results for geographic atrophy associated with age-related macular degeneration using subretinal cord blood platelet-rich plasma | |
| CN113577083A (zh) | 一种小分子化合物组合在制备预防和治疗视网膜损伤性疾病药物中的应用 | |
| WO2020228743A1 (zh) | 干细胞和细胞因子的组合及其在改善精子活力的用途 | |
| CN102920722A (zh) | 治疗眼底病的眼用制剂 | |
| JP3310994B2 (ja) | アレルギー治療剤 | |
| WO2026031770A1 (zh) | 立他司特在制备治疗视网膜动脉阻塞损伤的药物中的应用 | |
| CN113521309B (zh) | 人肝细胞生长因子基因在湿疹治疗中的应用及微针药械 | |
| Mohammadpour | Deep intrastromal injection of bevacizumab for the management of corneal neovascularization | |
| CN102258518A (zh) | 石杉碱甲在制备治疗青光眼和/或缺血诱发的视神经损伤的药物中的用途 | |
| CN117338700B (zh) | 功能水凝胶及其制备和在制备治疗青光眼药物中的应用 | |
| WO2025040177A1 (zh) | 一种适用于耳鼓给药的地塞米松磷酸钠冻干组合物及其制备方法 | |
| CN118924710A (zh) | 细辛脑在制备治疗和/或预防眼部疾病药物中的应用和一种组合物及其应用 | |
| KR102860024B1 (ko) | 이나보글리플로진을 포함하는 안질환의 예방 또는 치료용 약학적 조성물 | |
| CN120227379A (zh) | 芦可替尼在治疗年龄相关性黄斑变性中的应用 | |
| Perone et al. | Safety and efficacy of two ocular anesthetic methods for phacoemulsification: Topical anesthesia and viscoanesthesia (VisThesia™) | |
| JP2024528700A (ja) | 細胞喪失を治療又は阻害するためのヒスタチンの組み合わせ及び方法 |